| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |